Status:
WITHDRAWN
A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza
Lead Sponsor:
Kirby Institute
Collaborating Sponsors:
National Health and Medical Research Council, Australia
Conditions:
Pandemic Influenza
Eligibility:
All Genders
Brief Summary
This aim of this project is to evaluate the efficacy of neuraminidase inhibitors in patients who have a clinical diagnosis of pandemic influenza infection. The study is observational only. The primary...
Detailed Description
The aim of this study is to describe treatment outcomes in patients infected with pandemic influenza (the most likely case being a version of the influenza A H5N1 virus) including overall survival, th...
Eligibility Criteria
Inclusion
- Clinical diagnosis of pandemic influenza (consistent with the applicable clinical case definition)
- Provision of written informed consent or equivalent
- Intention to commence treatment with a neuraminidase inhibitor
Exclusion
- none
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00640302
Last Update
April 24 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
St Vincent's Hospital
Sydney, New South Wales, Australia, 2010
2
Prince of Wales Hospital
Sydney, New South Wales, Australia, 2031
3
Westmead Hospital
Sydney, New South Wales, Australia, 2145
4
Royal Brisbane Hospital
Brisbane, Queensland, Australia, 4000